Rosa Maria Iacobazzi

Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells

Amalia Azzariti, Rosa Maria Iacobazzi, R. Fonte et al. · Scientific Reports · 2019 · 153 citations · Full text

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

Simona Serratì, Michele Guida, R. Fonte et al. · Molecular Cancer · 2022 · 142 citations · Full text

Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents

Leonardo Pisani, Roberta Farina, Marco Catto et al. · Journal of Medicinal Chemistry · 2016 · 88 citations · Full text

Drug Target, Hmao B, Neurochemical Biomarkers +21

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer

Letizia Porcelli, Rosa Maria Iacobazzi, R. Fonte et al. · Cancers · 2019 · 85 citations · Full text

Pancreatic Cancer, Tgf-β Signaling Activation, Medicine +15

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study

Antonella Argentiero, Simona De Summa, R. Fonte et al. · Cancers · 2019 · 78 citations · Full text

Cancer Immunosurveillance, Pancreatic Cancer, Immunology +15